Lushang Freda Pharmaceutical Co (SHSE:600223) 3-Year EBITDA Growth Rate : -14.00% (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Lushang Freda Pharmaceutical Co 3-Year EBITDA Growth Rate?

Lushang Freda Pharmaceutical Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.09.

During the past 12 months, Lushang Freda Pharmaceutical Co's average EBITDA Per Share Growth Rate was -45.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -14.00% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 0.50% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 7.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Lushang Freda Pharmaceutical Co was 40.80% per year. The lowest was -27.90% per year. And the median was -0.70% per year.

Competitive Comparison of Lushang Freda Pharmaceutical Co's 3-Year EBITDA Growth Rate

For the Real Estate - Development subindustry, Lushang Freda Pharmaceutical Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lushang Freda Pharmaceutical Co's 3-Year EBITDA Growth Rate Distribution in the Real Estate Industry

For the Real Estate industry and Real Estate sector, Lushang Freda Pharmaceutical Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Lushang Freda Pharmaceutical Co's 3-Year EBITDA Growth Rate falls into.

Lushang Freda Pharmaceutical Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Lushang Freda Pharmaceutical Co (SHSE:600223) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Lushang Freda Pharmaceutical Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Lushang Freda Pharmaceutical Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Lushang Freda Pharmaceutical Co (SHSE:600223) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Real Estate » Real Estate » Lushang Freda Pharmaceutical Co Ltd (SHSE:600223) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

No. 9777 Jingshi Road, Building 5, Lixia District, Jinan City, CHN

Website

http://www.lshzy.com.cn

Lushang Freda Pharmaceutical Co Ltd formerly Lushang Health Industry Development Co Ltd is a real estate developer in China. The company is engaged in the development of office buildings, infrastructure, apartments, and hotels.

Lushang Freda Pharmaceutical Co (SHSE:600223) Headlines

No Headlines